News & Announcements

Weil Advises PSG Portfolio Company mPulse on Acquisitions of HealthTrio and Decision Point Healthcare Solutions

Weil is advising mPulse, a leader in conversational AI and digital engagement solutions for the healthcare industry and portfolio company of PSG Equity LLC, in the acquisition of HealthTrio and Decision Point Healthcare Solutions. HealthTrio is a leading provider of comprehensive health management and member engagement solutions and Decision Point is an innovative analytics and member experience optimization company.

"This combination aligns with our vision to make it easier for healthcare organizations to engage and align with their members, brokers, and providers," said Bob Farrell, CEO of mPulse. "By integrating the capabilities of mPulse, HealthTrio and Decision Point, we are now positioned to provide organizations with the ability to understand the needs of their population, design effective outcome improvement programs, and to efficiently operate those programs via advanced omni-channel communications."

The Weil team advising mPulse was led by Private Equity partner David Gail. The team also included Private Equity associates Patrick Hosch, Joe Schlemeier, Graham McHenry and Emma Conde; Executive Compensation & Benefits partner Jennifer Britz, associate Rebekah French, and associate Sanjana Rao; Technology & IP Transactions Co-Head Charan Sandhu, partner Olivia Greer and associates Phillip Grudzina, David Merck; Dominic Farchione and Sabrina Chishti; Employment counsel Celine Chan and associate Kate Belsito; Tax partner Jonathan Macke and associate Griffin Baker; as well as Banking & Finance partner Benton Lewis and associate Veronica Bonhamgregory.